The Patent Finder

Terms ending in 2039

AbbVie Inc.

Every in-force patent on AbbVie Inc.'s record whose computed term ends in 2039, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleHolderStatusExpiresConfidence
US 10,499,357Method and System for Transmission of Susi in the NAS Procedure
In force
 · High confidence
AbbVie Deutschland GmbH & Co. KGIn forceHigh confidence
US 10,508,113Inhibitors of Tyrosine Kinase 2 Mediated Signaling
In force
 · High confidence
AbbVie Inc.In forceHigh confidence
US 10,954,202Protein Tyrosine Phosphatase Inhibitors and Methods of Use Thereof
In force
 · High confidence
Calico Life Sciences LLCIn forceHigh confidence
US D1,034,191Container Cap
In force
 · High confidence
AbbVie Inc.In forceHigh confidence
US 11,542,239Elagolix Sodium Compositions and Processes
In force
 · High confidence
AbbVie Inc.In forceHigh confidence
US 11,293,927Screening Methods for Parp Modulators
In force
 · High confidence
AbbVie Biotechnology Ltd.In forceHigh confidence
US 11,149,043Prodrug Modulators of the Integrated Stress Pathway
In force
 · Medium confidence
Calico Life Sciences LLCIn forceMedium confidence
US 12,083,227Solid Pharmaceutical Formulations for Treating Endometriosis, Uterine Fibroids, Polycystic Ovary Syndrome or Adenomyosis
In force
 · Medium confidence
Neurocrine Biosciences, Inc.In forceMedium confidence
8 of 8 patents shown. Soonest term end first, then patent number.
5 of these are in force and held by AbbVie Inc..
Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited